Navigation Links
Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
Date:11/20/2008

companies in Europe and Asia have been expanding their therapeutic scope significantly in recent years," said Jim Dolan, Senior Vice President of Licensing and Business Development for Purdue. "Mundipharma's presence in oncology outside of the U.S. is now well-established, and we expect that the broad alliance with Infinity will give us the opportunity to bring to market a number of innovative, best-in-class treatments for cancer patients. In addition, this alliance will also build upon our core franchise in pain on a global basis, with FAAH, a potentially innovative new product for neuropathic pain."

"Infinity's mission is to discover, develop, and deliver to patients important medicines for the treatment of cancer," said Steve H. Holtzman, chair and chief executive officer of Infinity. "This alliance with Purdue and Mundipharma provides Infinity with the financial resources and independence to continue our productive discovery efforts, to expand our clinical development capabilities, and to build our own organization to commercialize our products in the United States. In a nutshell, we have the opportunity to realize all aspects of our mission in a manner that we believe will create meaningful treatments for patients and meaningful value for our shareholders."

The Purdue/Mundipharma/Napp independent associated companies are privately owned companies and joint ventures covering the world's pharmaceutical markets. The companies have particular expertise in drug delivery systems and these are applied to a range of analgesics, respiratory treatments, and cardiovascular drugs. The companies also have a growing presence in the oncology market, and products in the areas of attention deficit hyperactivity disorder, antiseptics and laxatives.


'/>"/>
SOURCE Purdue Pharma L.P.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. NIH grant to strengthen IU and Purdue program to educate physician-scientists
2. Purdue lab works to improve conditions at indoor swimming pools
3. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
4. Purdue researchers develop technology to detect cancer by scanning surface veins
5. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
6. Parkland Health & Hospital System Rolls Out Innovations PharmASSIST Technology Platform Across Nine Pharmacy Sites
7. NCPA Encourages Member Pharmacists to Consider Refraining From Selling Tobacco Products
8. Par Pharmaceutical Begins Shipment of Budesonide Inhalation Suspension Immediately
9. Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery
10. Kmart Pharmacy Celebrates GoldK Day for Seniors
11. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email: